medicinal charcoal Report issue

Botanical Experimental
AACT ChEMBL DrugBank PubChem

Active Ingredient History

NOW
  • Now
D&C Black #2 is the name, given by the FDA, for a highly pure form of carbon black prepared by combusting aromatic petroleum oil in the "oil furnace" process. It consists, essentially, of pure carbon. The Cosmetic, Toiletries and Fragrance Association (CTFA) petitioned the U.S. Food and Drug Administration (FDA) for approval to use carbon black in cosmetic formulations. The FDA granted approval on August 29, 2004, and now D&C Black #2 is used in all cosmetic products: mascaras, eyeliners, brush-on-brow, eyeshadows, and lipsticks.   NCATS

Chemistry

  • SMILES: [C]
  • InChIKey: ERROR
  • Mol. Mass: 12.0107
  • ALogP: 0.08
  • ChEMBL Molecule:
    charcoal, activated  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Drug Pricing (per unit)

United States

$0.0662 - $31.0000
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

activated carbon | activated charcoal | carbo activates | carbo activatus | carbon | carbon, activated | carbon, decolorizing | carbon, medicinal | carbosylane | carbo vegetabilis | charcoal | charcoal activated | charcoal-activated | charcoal,activated | charcoal, activated | detox-b | medicinal carbon | medicinal charcoal

Organizations (27)

Research & Development (27)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (22)

Approved Indications (1)


 

Poisoning

Experimental Indications - Clinical Trial Phases 1-4 (21)


 

Asthma (Phase 1)

Breast Diseases (Phase 3)

Breast Neoplasms (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 1)

Chronic Kidney Disease-Mineral and Bone Disorder (Phase 2)

Colonic Neoplasms (Phase 1)

Colorectal Neoplasms (Phase 1)

Depressive Disorder, Major (Phase 1)

Diabetes Mellitus, Type 2 (Phase 1)

Fecal Incontinence (Phase 3)

Healthy Volunteers (Phase 1)

Hemorrhage (Phase 4)

Lung Neoplasms (Phase 2)

Melanoma (Phase 3)

Multiple Sclerosis (Phase 3)

Pancreatic Neoplasms (Phase 1)

Pharmacokinetics (Phase 1)

Pulmonary Disease, Chronic Obstructive (Phase 2)

Sleep Initiation and Maintenance Disorders (Phase 1)

Small Cell Lung Carcinoma (Phase 1)

Therapeutic Equivalency (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 33
  • # of Trial Organizations: 27

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue